Hazard Ratio =

Related by string. * HAZARD . hazard : detach posing choking hazard . posing choking hazard . pose choking hazard . posing laceration hazard . poses choking hazard / Rating IO . Ratios . RATIO . RATIOS : Ratios eg Gross Margin . Bought Sold ratio . Relative Strength Ratio . efficiency ratios / = [031] . = [003] . = [019] . = [035] : Yard Freestyle =-#.# mg dL . = js enabled . 1 = .# . target = blank * *

Related by context. Frequent words. (Click for all words.) 66 TAXUS p value 64 confidence interval #.#-#.# 64 CI #.#-#.# [002] 64 statistically significant p = 63 placebo p = 63 P = .# 62 cerebrovascular events 62 % CI #.#-#.# [003] 62 lispro 62 achieved statistical significance 62 % CI #.#-#.# [007] 61 CI -#.# 60 mmol l 59 p = .# [002] 59 confidence interval CI 59 mL kg 59 g dl 58 XIENCE V vs. 58 μg kg 58 ximelagatran 58 μmol L 58 mg kg dose 58 thromboembolic 58 systemic embolism 58 median PFS 57 FOLFOX4 57 placebo p 57 % CI #.#-#.# [006] 57 p = 57 thromboembolism 57 tirofiban 57 % CI #.#-#.# [002] 57 annualized relapse 57 plus methotrexate 56 mg QD 56 Secondary endpoints included 56 pericardial effusion 56 HbA1c levels 56 thromboembolic events 56 p = #.# [004] 56 #mg/day [001] 56 HbA1C 56 mmol L 56 plus dexamethasone 56 mcg kg 56 p = #.# [002] 56 statistically significant p 56 nonfatal myocardial infarction 55 LVEF 55 Exacta £ 55 eplerenone 55 postop 55 colorectal carcinoma 55 QTc 55 clinically meaningful improvement 55 glimepiride 55 HbA 1c 55 biochemical recurrence 55 irbesartan 55 carotid intima media 54 RYGB 54 venous thromboembolic events 54 CI = 54 left ventricular systolic 54 pg ml 54 tamsulosin 54 hypoglycemic events 54 cerebrovascular accident 54 highest quintile 54 CK MB 54 paclitaxel eluting stents 54 μg L 54 glycated hemoglobin 54 events MACE 54 mEq L 54 pg mL 54 cardiovascular hospitalization 53 distant metastasis 53 FOLFIRI 53 unfractionated heparin 53 Secondary endpoints include 53 QTc prolongation 53 XELOX 53 nasopharyngitis 53 myocardial infarction stroke 53 ml min 53 revascularisation 53 severe hypoglycemia 53 plus prednisone 53 mineral density 53 ischemic cardiomyopathy 53 alteplase 53 estimated glomerular filtration 53 colorectal adenomas 53 gout flares 53 abciximab 53 haemorrhagic stroke 53 Tote £ 53 hypokalemia 53 Median survival 53 microvascular complications

Back to home page